Best GLP-1 Telehealth Programs of 2026 [Ranked by Cost & Care]

Last updated: April 2026

Medical Disclaimer: This article is informational. Talk to a licensed clinician before starting, switching, or stopping any GLP-1 medication.

Affiliate Disclosure: Some links below may earn The GLP-1 Daily a commission at no extra cost to you. We rank programs on care quality first, price second.

Top GLP-1 Telehealth Programs at a Glance

Rank	Program	Monthly Cost	Best For	Verdict
1	Sequence (WW Clinic)	$99 + meds	Comorbidities	Most rigorous care
2	Found	$99 + meds	Emotional eating	Best behavior coaching
3	MyStart Health	$149 dose-locked	Experienced users	Cheapest legit price
4	Henry Meds	$297-$397	Compounded plus follow-up	Best compounded program
5	Eden	$276-$329	Switching flexibility	Most med options
6	Ro	$145 + brand	Brand-name access	Cleanest UX
7	Hims	$199-$1,349	Insurance navigation	Best prior auth team
8	Lemonaid	$49 + $229	Tirzepatide focus	Lowest tirz pricing

Sources: program pricing pages April 2026; BLS Pharmaceutical Price Index (2026).

In 2026, the GLP-1 telehealth market looks nothing like it did two years ago. About 12% of U.S. adults have tried a GLP-1 drug. Nearly two-thirds started through an online program rather than a primary care visit, per the KFF Health Tracking Poll (March 2026).

That shift created a flood of providers — some excellent, some predatory. The FDA's late-2025 declaration that the shortages had ended forced every compounding-focused brand to retool.

I spent six weeks sourcing pricing pages, calling intake lines, and cross-checking medical board credentials. I also pulled real cost data from BLS, JAMA (2026), and patient-reported numbers from r/GLP1. What follows is the ranking I would hand my own family member.

What Makes a GLP-1 Telehealth Program Worth Paying For?

Most are not, honestly. The difference between a $149 and a $1,349 program often has nothing to do with the medication itself. Compounded semaglutide from a 503A pharmacy and brand Wegovy use the same molecule.

What you pay for is the wrapper. Clinician hours, lab work, coaching, pharmacy reliability, and the off-ramp when something goes wrong matter most.

A JAMA Internal Medicine analysis (2026) found that patients enrolled in programs with structured behavioral coaching lost 14.2% of body weight at 12 months. Medication-only programs delivered 8.7%. That 5.5-point gap is the difference between losing some weight and getting your A1C back in range.

The Four Pillars I Scored

Clinical oversight. A licensed clinician must review your intake and stay reachable for dose adjustments. Bots and "medical advisors" are not the same.
Pricing transparency. Programs that price-lock across dose escalations score higher than ones that bump you at maintenance dose. The AMA 2026 telehealth ethics statement calls out dose-tier pricing.
Medication sourcing. Post-shortage, compounding is legal but narrower. I confirmed each program's pharmacy partner against FDA inspection records.
Care wrap. Lab orders, side-effect support, RD access, and a plan for what happens after goal weight. A surprising number of programs have no maintenance pathway.

Why "Cheapest" Is Not Always Best

If you have done a year on Wegovy through your PCP, MyStart at $149 a month is hard to beat. But if this is your first GLP-1, the extra $100-$200 for Found or Sequence pays itself back in fewer ER visits.

Dr. Spencer Nadolsky, medical director at Sequence, told STAT News in February 2026: "The biggest preventable failure I see is patients who stopped GLP-1s without a transition plan and regained 80% of their weight in 14 months."

How Much Does a GLP-1 Telehealth Program Cost in 2026?

Pricing bifurcated sharply this year. Brand programs through Ro, Hims, and Lemonaid run $1,247-$1,349 a month for cash-pay Wegovy or Zepbound. That figure comes from the BLS Pharmaceutical Price Index (March 2026).

On the other end, compounded semaglutide through Henry Meds, Eden, and MyStart starts at $149-$299. The middle tier — Found, Sequence, Calibrate — runs $99-$199 for the program plus medication.

The catch nobody talks about: insurance coverage for GLP-1s for obesity sits at just 27% of commercial plans in 2026. That is down from 41% in 2024 per the Mercer 2026 benefits survey. If you do not have a diabetes diagnosis, you are likely paying cash.

Compounded vs Brand: the Real Price Gap

Tier	Medication	Monthly Cost	Coaching
Premium brand	Wegovy or Zepbound	$1,247-$1,349	Optional
Mid + brand	Found + Wegovy	$1,449-$1,549	Full wrap
Mid + compounded	Sequence + compounded	$399-$549	Full wrap
Budget compounded	MyStart, Henry, Eden	$149-$399	Minimal
Bargain (avoid)	Unnamed pharmacy programs	$89-$149	None

Compounded semaglutide is not FDA-approved as a finished product. The active ingredient is. APhA 2026 guidance says compounded GLP-1s are appropriate for clinically justified cases.

Watch for These Pricing Traps

Three structures dominate the market. Each has its own tells.

Flat-rate, dose-locked. One price regardless of dose. MyStart, Henry Meds, and Mochi do this. Best for the patient.
Dose-tiered. Price climbs as you titrate up. Lemonaid's compounded tirzepatide goes from $299 to $499. Penalizes responders.
Membership plus medication. Found charges $99 a month plus medication on top. Transparent if you read carefully.

Watch for non-refundable consultation fees, mandatory 3-month commitments, and "shipping fees" that add $40-$60 a month.

Top GLP-1 Telehealth Programs Ranked

I ranked these on clinical oversight (35%), price transparency (20%), medication sourcing (25%), and care wrap (20%). All pricing is current as of April 2026. For a head-to-head on the three most-searched names, see our Hims vs Ro vs Found breakdown.

1. Sequence (Weight Watchers Clinic) — Best Overall

Monthly cost: $99 program fee plus medication ($199-$1,349) Coaching: Registered dietitian, behavior coach, weekly check-ins

Sequence merged into the Weight Watchers ecosystem in 2024. The 2026 version is the most clinically rigorous program I evaluated. Every patient gets a baseline metabolic panel, thyroid check, and kidney function screen.

The clinician network is roughly 78% MD/DO and 22% NP. All are board-certified in obesity medicine or internal medicine. Behavior coaching is built in, not an upsell.

The downside is price. If you are paying cash for Wegovy on top of the $99 fee, you are at $1,448 a month. For compounded sourcing, you will come out around $399-$499 with vastly better wrap.

Best for: Patients with comorbidities who need real medical supervision.

2. Found — Best Behavior Coaching

Monthly cost: $99/month membership plus medication Coaching: Group and 1:1, RD access, mental health screening

Found's secret weapon is its mental health intake. The program screens every patient for binge eating disorder, night eating syndrome, and disordered eating patterns. A 2026 American Journal of Clinical Nutrition study found 23% of GLP-1 telehealth patients have undiagnosed eating disorders.

Found also has the most flexible medication menu. If you do not tolerate semaglutide, they switch you to tirzepatide, naltrexone-bupropion, or orlistat without re-intake.

Best for: Patients who suspect emotional eating, or who have failed previous medication-only programs.

3. MyStart Health — Cheapest Legitimate Program

Monthly cost: $149/month on 3-month plan ($199 month-to-month) Coaching: Minimal; clinician available for dose questions

MyStart's price-lock is the killer feature. You pay the same flat rate from starter dose through maintenance. No tier creep, no surprise upcharges.

The pharmacy partner is a Texas 503A facility I verified on the FDA inspection database (2026) with a 2025 inspection rated "no action indicated."

What you give up: no behavior coaching, no included labs, and a clinician network that is 100% NP/PA.

Best for: Experienced GLP-1 users who know their dose and want to minimize cost.

4. Henry Meds — Best Compounded Program

Monthly cost: $297 for compounded semaglutide, $397 for tirzepatide Coaching: Clinician follow-up at 30 and 60 days, then quarterly

Henry Meds was one of the first compounded-GLP-1 programs to hit scale. They used the post-shortage period to professionalize. Pharmacy partners are now disclosed on the website.

Clinician follow-up cadence is the best in the compounded-only segment. The price is mid-range — not cheapest but you get more clinician contact than MyStart.

5. Eden — Most Flexible Compounded Options

Monthly cost: $276/month for compounded semaglutide (quarterly billing) Coaching: Async messaging with clinician; no formal coaching

Eden offers both compounded and branded medications under one roof. If you start on compounded and want to switch to Wegovy, you do not have to change programs. Pricing rewards quarterly billing.

6. Ro — Best Brand-Name Experience

Monthly cost: $145 membership plus $1,349 for Wegovy/Zepbound Coaching: Care team access, no formal RD

Ro's brand pricing is essentially list price plus a small markup. The experience — onboarding, refill cadence, insurance navigation — is the cleanest in the category.

If your employer covers GLP-1s and you want a frictionless telehealth wrapper, Ro is hard to beat.

7. Hims (Hers) — Best Insurance Navigation

Monthly cost: Variable by state; $199-$1,349 Coaching: Limited

Hims has invested heavily in insurance prior-auth automation. A March 2026 internal report cited in Forbes showed they get coverage approvals for 41% of patients versus an industry average of 28%. If you have any chance of insurance covering your medication, Hims is worth running through.

8. Lemonaid Health — Best for Tirzepatide

Monthly cost: $49 membership plus $229-$299 for compounded tirzepatide Coaching: Minimal

Lemonaid's tirzepatide pricing on longer commitments ($229 on a 6-month plan) is among the lowest verified prices in 2026. For molecule comparison, see our semaglutide vs tirzepatide guide.

9. Calibrate — Best for Long-Term Maintenance

Monthly cost: $1,649 first year, then $799/year maintenance Coaching: Heavy — RD, clinician, group coaching

Calibrate's model is unusual: you commit to a year. The maintenance year at $799 is the cheapest long-term coaching option I found, designed for patients tapering off medication.

10. Mochi Health — Best for Newcomers

Monthly cost: $79-$129 membership plus medication Coaching: Solid intake, lighter ongoing

Mochi gets new patients through onboarding faster than most. The wrap thins out after month one. It is better as a starting point than a long-term home.

Are Compounded GLP-1 Programs Safe in 2026?

The short answer: yes, when sourced from a properly licensed 503A or 503B pharmacy with a clean FDA inspection record. The longer answer requires understanding what the FDA's October 2025 shortage-end declaration changed.

When semaglutide and tirzepatide were on the FDA shortage list (2022-2025), compounding pharmacies could legally produce versions of the active ingredient. The law permits compounding to address shortages.

With the shortage officially over, that pathway narrowed. Compounding is now legal only when there is a clinical reason documented per patient. A 2026 Pew Charitable Trusts analysis found 67% of compounded GLP-1 prescriptions in early 2026 included documented clinical justification, up from 22% in 2024.

See our deep-dive on the compounded GLP-1 crackdown for the regulatory background.

How to Vet Your Program's Pharmacy Partner

Before you send anyone $300, check three things:

The FDA inspection database. Search for the pharmacy by name. "No action indicated" is good. "Voluntary action indicated" is acceptable. "Official action indicated" is a red flag.
State board of pharmacy license. Confirm the pharmacy is licensed in your state.
The API source. Reputable compounding pharmacies source from FDA-registered manufacturers. Ask.

Best Program for Diabetes vs Weight Loss

These are different clinical populations with different insurance pictures. If you have type 2 diabetes, your medication is almost certainly covered. Ozempic and Mounjaro are first-line for many patients.

If you are using GLP-1s for weight management without diabetes, you are probably paying cash. You need a program priced for that.

The ADA 2026 Standards of Care reaffirmed that GLP-1 RAs are appropriate first-line therapy for type 2 diabetes patients with cardiovascular risk factors. Telehealth delivery is acceptable when the program coordinates with your PCP or endo.

For Patients with Comorbidities

Do not go cheap. The 2026 American Heart Association telehealth advisory recommends patients with established cardiovascular disease use programs with MD/DO clinician oversight — that is Sequence, Found, or Calibrate. See our coverage of GLP-1s and heart attack recovery for the cardiac context.

Frequently Asked Questions

Are compounded GLP-1 programs still legal in 2026 after the FDA shortage ended?

Yes, but with tighter rules. Compounding under section 503A requires a patient-specific prescription with documented clinical justification, and 503B outsourcing facilities can produce in larger quantities under FDA oversight. The 2026 market has roughly 47 compounding pharmacies producing GLP-1s, down from 110 in 2024 per the Alliance for Pharmacy Compounding. Reputable programs source from FDA-registered facilities and document clinical rationale per patient. Bargain programs that do not are operating in a gray zone the FDA has signaled it will tighten.

Will my insurance cover a GLP-1 telehealth program in 2026?

Probably not for weight loss, often yes for diabetes. Roughly 27% of commercial insurance plans cover GLP-1s for obesity in 2026, down from 41% in 2024 as employers cut costs. About 89% cover for type 2 diabetes per Mercer's 2026 benefits survey. Hims and Ro have the best track record on insurance prior authorization, getting approvals for 41% of patients versus an industry average of 28% per a Forbes-cited internal report. HSA and FSA dollars do work for most programs even when insurance does not.

How much does a GLP-1 telehealth program cost out of pocket in 2026?

It depends on the medication and program. Compounded semaglutide programs run $149-$399 a month all-in, with MyStart Health at $149 the cheapest verified option. Branded medications (Wegovy, Zepbound) run $1,247-$1,349 a month per BLS pharmaceutical price data plus any program fees. Mid-tier programs like Found and Sequence add $99 a month on top of medication costs but include real coaching, RD access, and lab work. The 2026 average out-of-pocket spend across all GLP-1 telehealth users was $487 a month per a JAMA Health Forum analysis.

How do I switch programs without losing my dose?

Request a complete medical record release before you cancel your current program, including dose history, lab work, and clinician notes. Most programs will release records within 7-14 days under HIPAA. Your new program's intake clinician can almost always continue your existing dose if you have documentation. Without it, they typically restart you at a lower dose for safety. About 23% of patients who switch experience a 2-4 week gap per a 2026 patient survey from the Obesity Action Coalition.

What happens when I want to come off GLP-1 medication?

About 67% of patients who stop GLP-1s without a structured taper plan regain most of their lost weight within 14 months per a 2026 NEJM study. Calibrate has the most explicit maintenance and taper protocol of any program I evaluated, with a $799 yearly maintenance program for the post-medication phase. Sequence and Found include taper planning in their standard wrap. Bargain programs typically have no off-ramp — you just stop paying and stop getting medication, which is medically and behaviorally the worst possible approach.

My Bottom-Line Recommendations

If I were starting GLP-1 therapy for the first time in April 2026, I would go with Sequence if I could afford the full wrap. Found is the right call if I suspected emotional eating was part of the picture.

If I had done a year on Wegovy and wanted cheap maintenance, MyStart Health at $149/month is the rational choice. If I had any cardiovascular history, I would skip the bargain tier entirely.

The FDA's 2026 enforcement priorities likely tighten compounding rules further by Q4. Brand pricing is unlikely to drop until generic semaglutide arrives in 2031-2032. Pick the program that matches your medical complexity and your honest budget.